COVID-19 Update: As per reports the Delta variant mutates can be resistant to antibodies

The Delta variant (B.1.617.2) of SARS-CoV-2 was first detected in India in October 2020, which has been classified by the World Health Organization as a variant of concern.

The Times of India has reported that, the Delta variant of the coronavirus has transformed into a version that could possibly be resistant to monoclonal antibodies cocktail used in COVID-19 treatment.

The Delta variant (B.1.617.2) of SARS-CoV-2 was first detected in India in October 2020 and has been classified by the World Health Organization as a variant of concern.

Public Health England the UK government body, said that as of June 7, India has reported six cases of Delta-AY.1. Delta-AY.1 has acquired the transfix protein that has reported K417N, as the report said citing  from GISAID.

On June 7 2021, total 63 genomes of Delta with K417N have been identified on GISAID. The countries such as  Canada 1 case, Germany 1 case, Russia 1 case, Nepal 2 cases, Switzerland 4 cases, India 6 cases, Poland 9 cases, Portugal 12 cases, Japan 13 cases and USA 14 cases, as recorded by PHE said on June 11 2021 in the updated document of coronavirus variants. Currently England has 36 cases reported.

It was first detected in South Africa, the K417N mutation is also one of the mutations found in the Beta variant (B.1.351) of SAR-CoV-2.

Dr. Scaria on Twitter gave some insight into the emerging lineages of Delta variant of the coronavirus.

The tweet added that “the number of genomes are now available for the lineage AY.1 / B.1.617.2.1 from across the world, this sequences are mostly from Europe, Asia and America. The travel histories are not readily available to make assumptions.”

 

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy